Brian Price Ruby
Nessuna posizione attualmente
Profilo
Brian Price Ruby served as the Chief Executive Officer at Carbon Nanoprobes, Inc. from 2003 to 2010.
He also worked as an Associate at Morgan Stanley & Co. LLC from 2013 to 2017.
Prior to his career, he completed his undergraduate degree from The Trustees of Columbia University in The City of New York.
Precedenti posizioni note di Brian Price Ruby
Società | Posizione | Fine |
---|---|---|
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Analyst-Equity | 01/02/2017 |
Carbon Nanoprobes, Inc.
Carbon Nanoprobes, Inc. Medical SpecialtiesHealth Technology Dubbed the photographers of nanotechnology, Carbon Nanoprobes, Inc. is making a name as experts in imaging the extremely small. CNP manufactures novel devices for high-end, high-resolution R&D and production imaging environments. These devices are made possible by using carbon nanotube probes for the atomic force microscope. CNP products include Superior metrology solutions for semiconductor manufacturing, Cost effective, efficient, high-resolution images for nanoscale research, and Fast and efficient high-resolution protein-imaging solutions for structural biology and drug discovery. The most exciting and cutting edge area of science today is taking place on the scale of only a few atoms. Nanotechnology promises advances in chip design, drug discovery and advanced materials. The ability to push the edge of nanotechnology necessarily relies upon tools and instruments that can touch, feel and see at the nanoscale. CNP is commercializing a device promising interaction with samples as small as a single molecule. CNProbes is committed to the mass fabrication of nanostructured Atomic Force Microscope (AFM) consumables. Its introduction of the first commercially viable carbon nanotube probe will provide industries from semiconductor and biopharmaceutical to corporate research and academia, an instrument capturing the ballooning demand for more accurate, high-resolution imaging solutions. With the advent of the mass-production of carbon nanotube tips, the company can multiply the power of the atomic force microscope to unprecedented levels. | Corporate Officer/Principal | 01/10/2010 |
Formazione di Brian Price Ruby
The Trustees of Columbia University in The City of New York | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Finance |
Carbon Nanoprobes, Inc.
Carbon Nanoprobes, Inc. Medical SpecialtiesHealth Technology Dubbed the photographers of nanotechnology, Carbon Nanoprobes, Inc. is making a name as experts in imaging the extremely small. CNP manufactures novel devices for high-end, high-resolution R&D and production imaging environments. These devices are made possible by using carbon nanotube probes for the atomic force microscope. CNP products include Superior metrology solutions for semiconductor manufacturing, Cost effective, efficient, high-resolution images for nanoscale research, and Fast and efficient high-resolution protein-imaging solutions for structural biology and drug discovery. The most exciting and cutting edge area of science today is taking place on the scale of only a few atoms. Nanotechnology promises advances in chip design, drug discovery and advanced materials. The ability to push the edge of nanotechnology necessarily relies upon tools and instruments that can touch, feel and see at the nanoscale. CNP is commercializing a device promising interaction with samples as small as a single molecule. CNProbes is committed to the mass fabrication of nanostructured Atomic Force Microscope (AFM) consumables. Its introduction of the first commercially viable carbon nanotube probe will provide industries from semiconductor and biopharmaceutical to corporate research and academia, an instrument capturing the ballooning demand for more accurate, high-resolution imaging solutions. With the advent of the mass-production of carbon nanotube tips, the company can multiply the power of the atomic force microscope to unprecedented levels. | Health Technology |
- Borsa valori
- Insiders
- Brian Price Ruby